Nickolas S. Tabraue
President, Director, & COO
Mr. Nickolas Tabraue is an industry veteran having 9 years of professional experience in the nutraceutical, dietary supplement field, as well as retail corporate management. Mr. Tabraue is well versed in his skills and knowledge of supplements, retail management, and customer service. His management experience at The Vitamin Shoppe encompassed the management of four different location, one being the company’s highest volume and another included the restructuring of a non-perfroming high volume store achieving high operating levels in operations, service, inventory compliance, and sales.
Dr. Michel Aube
CEO & CSO
Dr. Michel Aubé has wide-ranging expertise in the life sciences. As a microbiologist he furthered his graduate studies at Laval University, earning a Master’s degree in Cell Biology and Molecular Physiology as well as a PhD in Physiology-Endocrinology. In addition, he created and taught three postdoctoral courses in Immunology. His scientific research in Sexually Transmitted Infections (STIs), Cancer and Stem Cell biology has been published in several prestigious medical journals. Dr. Aubé has received a number of Awards for Excellence from the Network for environmental health research and childhood diseases.
Sergio Castillo, who moved to Miami when he was only 16, is a Current marketing consultant for few firms including Cloud Accounting, La Familia Media, Fresh Press Miami, Goodlife Miami, as well as Abdon Entertainment. He started his first company in 2008 called “Goodlife Miami, LLC”. In 2010, his second company was started named Fresh Press, LLC. His third company was founded in 2012, called La Familia Media, LLC. As the time passed, he’s learned everything it takes to run the marketing for many successful companies, and how he takes his expertise into the field of medicinal marijuana. As the new CMO of Earth Science Tech, Inc there seems to be no limit to what he can achieve.
Chief Sales Officer
Mr. Gabriel Aviles has extensive knowledge in the holistic health, herbal supplements and health food industry. Mr. Gabriel Aviles and Emerald Tablet Development Group of Florida specialize in developing and distributing science based nutritional products in the Alternate Medicine and Health Food industry. Mr. Gabriel Aviles has a strong interest in distributing all natural, herbal, botanicals and alternative medicine type products throughout Florida and other various markets. Mr. Aviles has extensive experience as a professional health and supplement advisor as well as food/nutrition adviser. Mr. Aviles is focused on advising and educating consumers on health and wellness issues according to what supplement is best suited for each individual’s need. He has a Bachelor of Science (BS) in Alternative and Complementary Medicine and Medical Systems. Some of his interests include Alternative Medicine, Bio – Chemistry, Biology, Music, Business, Nutrition, Human Anatomy, History, and Martial Arts.
Issa El-Cheikh PhD: Dr. Issa El-Cheikh has over 25 years of experience in international finance, accounting, operations, business planning and sales. He has managed the financial operations of manufacturing concerns with up to 300 employees and $200 million in sales. Dr. Issa El-Cheikh has had significant experience including budgeting, planning and execution of large scale transitions in the public and private sectors.
For the past 22 years Dr. Issa El-Cheikh has played a key role as a Vice-President in the automobile industry helping to execute large purchases, acquisitions, takeovers, as well as financial analysis and budgeting. For 4 years Dr. Issa El-Cheikh worked as a Vice President in Finance with Rosenau Power Sports and 17 years as a Vice President of Finance and controller for Auto Motive Group. Dr. Issa El-Cheikh worked for the United Nations for 6 years as a control officer and accounting aide from 1985 until 1991, Dr. Issa El-Cheikh has two master degrees in Accounting and finance and two PhD’s in accounting and finance.
Advisory Board Members
Laurent Azoulay, PhD.
Laurent Azoulay, Ph.D., has joined both the Cannabis Therapeutics Inc. and Earth Science Pharmaceutical Inc. Advisory Boards. He is an Associate Professor of Oncology at McGill University, where he actively researches cancer pharmacoepidemiology, which includes evaluating the safety of cancer drugs at a societal level.
After receiving his PhD in 2007 from the Université de Montréal, he completed a postdoctoral fellowship in pharmacoepidemiology at the Department of Epidemiology, Biostatistics and Occupational Health, McGill University. He then joined the Gerald Department of Oncology as an Assistant Professor in 2009. In 2016, he was promoted to the rank of Associate Professor with a cross-appointment with the Department of Epidemiology, Biostatistics and Occupational Health.
Chandra Panchal, PhD.
Chandra Panchal, Ph.D., has joined the Cannabis Therapeutics Inc., Earth Science Pharmaceutical Inc., and Earth Science Tech Inc. Advisory Boards. He is a serial entrepreneur with a wealth of expertise acquired from 28 years of experience in the biotech/pharmaceutical sector.
Dr. Panchal founded Axcelon in 2001 and was a co-founder of Procyon Biopharma Inc., a publicly traded biotechnology company involved in the development of wound healing, cancer therapeutic, and diagnostic products. Now known as Ambrilia BioPharma Inc., the company listed on the Alberta Stock Exchange in 1998 and the TSX in 2000. He served as Procyon Biopharma Inc.’s Chairman, President, and CEO; and Ambrilia Biopharma Inc.’s Senior Executive Vice-President, Business Development, Licensing, and Intellectual Property in charge of both out-licensing, in-licensing and M&A activities. He retired from Ambrilia Biopharma Inc. in February 2008.
Since then, Dr. Panchal has been actively involved in Axcelon. Prior to founding Procyon Biopharma Inc., Dr. Panchal was a senior scientist/group leader supervising activities related to yeast genetics, fermentations, and product development at John Labatt Ltd., a multinational food and beverage company. Dr. Panchal sits on the board of directors of several public and private companies. He has authored/co-authored over 60 scientific papers and has edited a book entitled Yeast Strain Selection. Dr. Panchal has been an Adjunct Professor at the University of Western Ontario where he obtained his Ph.D. in biochemical engineering.
Domenico Fuoco, PhD.
Domenico Fuoco, Ph.D., has joined the Cannabis Therapeutics Inc. Advisory Board. Dr. Fuoco has over 16 years’ experience in the research and development of innovative solutions for the pharmaceutical industry. Dr. Fuoco trained at the prestigious Department of Oncology of McGill University Health Centre (MUHC) in Montreal, from 2012 to 2015. During this time, Dr. Fuoco worked on the next generation of medications for AVEO Oncology and Helsinn Therapeutics. Prior to this, Dr. Fuoco obtained his PhD and Post-Doc training in medicinal chemistry and drug discovery at the University of Perugia in Italy with further studies at the University of Salamanca School of Pharmacy in Spain.
Dr. Fuoco is recognized for the transdisciplinary approach of his work. In 2010, Dr. Fuoco was Principal Scientist of the Italian Mission in Amazonia, Bogotà, Colombia. Dr. Fuoco’s publications cover a wide-range of chemical fields, from functional foods to autoimmune diseases. In 2015, Dr. Fuoco was honored with the prestigious Dr. Henry Shibata Fellowship from the Cedar Cancer Foundation for his work in the field of palliative care. Dr. Fuoco is an active member of the Italian Canadian Community Foundation and is very active within his community. He is also the chairman from Smart Medicines Consortium for the advancement of health care.
Dr. Fuoco’s expertise in human health and functional foods are highly valued as strategic assets by ETST.
Calvin Higgins, M.D.
Calvin Higgins, M.D., has joined the Earth Science Tech Inc. Advisory Board. Dr. Calvin Higgins is board-certified in internal medicine. Diplomate of the American Board of Internal Medicine. He was born in Kingston, Jamaica. He came to the United States in 1979. He attended Cornell Medical School and graduated in 1985. In 1998, he completed his residency at Lenox Hill Medical Center in Manhattan, New York in Internal Medicine. In 1998 he moved to Florida and completed 3 years in office-based medicine. He then moved onto hospital-based medicine in 2001 to present. Dr. Higgins is affiliated with Memorial Hospital Miramar, Memorial Hospital Pembroke, Memorial Hospital West and Memorial Regional Hospital.
Dr. Higgins has a great core for alternative medicine. He always encourages his patients to seek lifestyle changes in diet, exercise, meditation and mental wellness, just to name a few.
Moutih Rafe, PhD.
Dr. Moutih Rafei has been an Assistant Professor in the Department of Pharmacology & Physiology of the Université de Montréal since 2013. He completed a PhD in Experimental Medicine at McGill University and his post-doctoral training in Immunobiology at the Université de Montréal. During his training, Dr. Rafei accumulated profound knowledge and insight in the fields of T-cell development and stem cell biology, cancer immunotherapy, and autoimmune diseases. He is also actively involved in the discovery and development of small molecules that may stimulate or inhibit the immune system for the treatment of certain catastrophic illnesses.